These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 8239504)
1. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition. Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504 [TBL] [Abstract][Full Text] [Related]
2. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells. Houghton JA; Morton CL; Adkins DA; Rahman A Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921 [TBL] [Abstract][Full Text] [Related]
3. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin. Iigo M; Nishikata K; Hoshi A Jpn J Cancer Res; 1992 Apr; 83(4):392-6. PubMed ID: 1387127 [TBL] [Abstract][Full Text] [Related]
4. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase. van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671 [TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718 [TBL] [Abstract][Full Text] [Related]
6. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Chu E; Zinn S; Boarman D; Allegra CJ Cancer Res; 1990 Sep; 50(18):5834-40. PubMed ID: 1697502 [TBL] [Abstract][Full Text] [Related]
7. Time course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin. Peters GJ; van Groeningen CJ; van der Wilt CL; Meijer S; Smid K; Laurensse E; Pinedo HM Semin Oncol; 1992 Apr; 19(2 Suppl 3):26-35. PubMed ID: 1557655 [TBL] [Abstract][Full Text] [Related]
8. Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells. van der Wilt CL; Smid K; Aherne GW; Noordhuis P; Peters GJ Eur J Cancer; 1997 Mar; 33(3):471-8. PubMed ID: 9155534 [TBL] [Abstract][Full Text] [Related]
9. Dual modulation by l-leucovorin and recombinant human interferon alpha 2a of 5-fluorouracil antitumor activity against the human colon carcinoma xenograft Co-4. Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Kuo TH; Saikawa Y; Teramoto T; Kitajima M J Interferon Cytokine Res; 1995 Dec; 15(12):1089-93. PubMed ID: 8746791 [TBL] [Abstract][Full Text] [Related]
10. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil. Peters GJ; van der Wilt CL; van Groeningen CJ; Smid K; Meijer S; Pinedo HM J Clin Oncol; 1994 Oct; 12(10):2035-42. PubMed ID: 7931471 [TBL] [Abstract][Full Text] [Related]
11. Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells. Chen TL; Erlichman C Cancer Chemother Pharmacol; 1992; 30(5):370-6. PubMed ID: 1380407 [TBL] [Abstract][Full Text] [Related]
13. Comparative cytotoxicity of folate-based inhibitors of thymidylate synthase and 5-fluorouracil +/- leucovorin in MGH-U1 cells. Erlichman C; Mitrovski B Cancer Chemother Pharmacol; 1994; 34(1):51-6. PubMed ID: 8174202 [TBL] [Abstract][Full Text] [Related]
14. Tumor size and origin determine the antitumor activity of cisplatin or 5-fluorouracil and its modulation by leucovorin in murine colon carcinomas. Van Laar JA; Rustum YM; Van der Wilt CL; Smid K; Kuiper CM; Pinedo HM; Peters GJ Cancer Chemother Pharmacol; 1996; 39(1-2):79-89. PubMed ID: 8995503 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil. Spears CP; Gustavsson BG; Berne M; Frösing R; Bernstein L; Hayes AA Cancer Res; 1988 Oct; 48(20):5894-900. PubMed ID: 3167844 [TBL] [Abstract][Full Text] [Related]
16. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines. Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999 [TBL] [Abstract][Full Text] [Related]
17. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Johnston PG; Drake JC; Trepel J; Allegra CJ Cancer Res; 1992 Aug; 52(16):4306-12. PubMed ID: 1643628 [TBL] [Abstract][Full Text] [Related]
18. Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase. Davis ST; Berger SH Mol Pharmacol; 1989 Apr; 35(4):422-7. PubMed ID: 2523018 [TBL] [Abstract][Full Text] [Related]
19. [Modulation of the biochemical effect of 5-fluorouracil (5-FU) by leucovorin measured by thymidylate synthase activity and nucleoside incorporation into DNA]. Kau B; Rieger M; Sauer H Onkologie; 1990 Dec; 13(6):453-7. PubMed ID: 2092282 [TBL] [Abstract][Full Text] [Related]
20. Effects of leucovorin on idoxuridine cytotoxicity and DNA incorporation. Greene RF; Collins JM Cancer Res; 1990 Oct; 50(20):6652-6. PubMed ID: 2208128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]